• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性胰腺癌的前驱病变:PanIN、IPMN 和 MCN。

Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.

机构信息

Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus Dresden, TU Dresden, Fetscher Street 74, 01307 Dresden, Germany.

Institute for Pathology, University Hospital Carl Gustav Carus Dresden, TU Dresden, Fetscher Street 74, 01307 Dresden, Germany.

出版信息

Biomed Res Int. 2014;2014:474905. doi: 10.1155/2014/474905. Epub 2014 Mar 24.

DOI:10.1155/2014/474905
PMID:24783207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3982269/
Abstract

Pancreatic cancer is still a dismal disease. The high mortality rate is mainly caused by the lack of highly sensitive and specific diagnostic tools, and most of the patients are diagnosed in an advanced and incurable stage. Knowledge about precursor lesions for pancreatic cancer has grown significantly over the last decade, and nowadays we know that mainly three lesions (PanIN, and IPMN, MCN) are responsible for the development of pancreatic cancer. The early detection of these lesions is still challenging but provides the chance to cure patients before they might get an invasive pancreatic carcinoma. This paper focuses on PanIN, IPMN, and MCN lesions and reviews the current level of knowledge and clinical measures.

摘要

胰腺癌仍然是一种可怕的疾病。高死亡率主要是由于缺乏高度敏感和特异性的诊断工具,而且大多数患者在晚期和不可治愈的阶段被诊断出来。过去十年中,关于胰腺癌前体病变的知识有了显著增长,现在我们知道主要有三种病变(PanIN、IPMN 和 MCN)是导致胰腺癌发展的原因。这些病变的早期检测仍然具有挑战性,但为患者提供了在可能患上侵袭性胰腺癌之前治愈的机会。本文重点介绍 PanIN、IPMN 和 MCN 病变,并回顾当前的知识水平和临床措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/88440a802bb5/BMRI2014-474905.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/9213006136cf/BMRI2014-474905.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/0bcc377a6650/BMRI2014-474905.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/8984c241094b/BMRI2014-474905.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/dbce3e9d1444/BMRI2014-474905.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/9f7cf89eccee/BMRI2014-474905.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/88440a802bb5/BMRI2014-474905.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/9213006136cf/BMRI2014-474905.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/0bcc377a6650/BMRI2014-474905.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/8984c241094b/BMRI2014-474905.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/dbce3e9d1444/BMRI2014-474905.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/9f7cf89eccee/BMRI2014-474905.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb2c/3982269/88440a802bb5/BMRI2014-474905.006.jpg

相似文献

1
Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.散发性胰腺癌的前驱病变:PanIN、IPMN 和 MCN。
Biomed Res Int. 2014;2014:474905. doi: 10.1155/2014/474905. Epub 2014 Mar 24.
2
Precancerous lesions of the pancreas.胰腺的癌前病变。
Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):299-322. doi: 10.1016/j.bpg.2013.04.001.
3
A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.巴尔的摩胰腺肿瘤前体病变共识会议的修订分类系统及建议
Am J Surg Pathol. 2015 Dec;39(12):1730-41. doi: 10.1097/PAS.0000000000000533.
4
Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.丝氨酸蛋白酶抑制剂Kazal 1型和表皮生长因子受体在胰腺导管腺癌、导管内乳头状黏液性肿瘤及胰腺上皮内瘤变中均有表达。
J Hepatobiliary Pancreat Sci. 2013 Aug;20(6):620-7. doi: 10.1007/s00534-012-0587-6.
5
[Intraepithelial neoplasms (PanIN) and intraductal papillary-mucinous neoplasms (IPMN) of the pancreas as precursor lesions of pancreatic carcinoma].胰腺上皮内瘤变(PanIN)和导管内乳头状黏液性肿瘤(IPMN)作为胰腺癌的前驱病变
Med Klin (Munich). 2007 Feb 15;102(2):127-35. doi: 10.1007/s00063-007-1013-8.
6
Dilemma in classifications of possible precursors of pancreatic cancer involving the main pancreatic duct: PanIN or IPMN?涉及主胰管的胰腺癌可能前驱病变分类中的困境:胰腺上皮内瘤变还是导管内乳头状黏液性肿瘤?
J Gastroenterol. 2003;38(3):311-3. doi: 10.1007/s005350300057.
7
Pathology of Pancreatic Cancer Precursor Lesions.胰腺癌前驱病变的病理学
Surg Pathol Clin. 2016 Dec;9(4):561-580. doi: 10.1016/j.path.2016.05.004. Epub 2016 Oct 12.
8
Precursor lesions in pancreatic cancer: morphological and molecular pathology.胰腺癌的癌前病变:形态学和分子病理学。
Pathology. 2011 Apr;43(3):183-200. doi: 10.1097/PAT.0b013e3283445e3a.
9
Precursors to invasive pancreatic cancer.浸润性胰腺癌的前驱病变
Adv Anat Pathol. 2005 Mar;12(2):81-91. doi: 10.1097/01.pap.0000155055.14238.25.
10
[Precursors of Pancreatic cancer: Intraepithelial Neoplasia (PanIN) and Intraductal Papillary Mucinous Neoplasms (IPMN)].[胰腺癌的前驱病变:上皮内瘤变(PanIN)和导管内乳头状黏液性肿瘤(IPMN)]
Magy Seb. 2009 Feb;62(1):22-6. doi: 10.1556/MaSeb.62.2009.1.6.

引用本文的文献

1
The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets.黏蛋白家族在肺癌中的多方面作用:从预后生物标志物到有前景的靶点。
Front Immunol. 2025 Jun 27;16:1608140. doi: 10.3389/fimmu.2025.1608140. eCollection 2025.
2
Proteomics in pancreatic cancer.胰腺癌中的蛋白质组学
Biomark Res. 2025 Jul 6;13(1):93. doi: 10.1186/s40364-025-00805-y.
3
Three-dimensional assessments are necessary to determine the true, spatially resolved composition of tissues.三维评估对于确定组织的真实、空间分辨组成是必要的。

本文引用的文献

1
mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).单抗 Das-1 特异性针对高危和恶性的导管内乳头状黏液性肿瘤(IPMN)。
Gut. 2014 Oct;63(10):1626-34. doi: 10.1136/gutjnl-2013-306219. Epub 2013 Nov 25.
2
[Intraductal papillary mucinous neoplasm of the pancreas (IPMN)--standards and new aspects].[胰腺导管内乳头状黏液性肿瘤(IPMN)——标准与新进展]
Zentralbl Chir. 2014 Jun;139(3):308-17. doi: 10.1055/s-0033-1350892. Epub 2013 Nov 15.
3
Cytological criteria of high-grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms.
Cell Rep Methods. 2025 Jun 16;5(6):101075. doi: 10.1016/j.crmeth.2025.101075. Epub 2025 Jun 9.
4
Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research.新发糖尿病与胰腺癌研究的当前范式及未来展望
Front Pharmacol. 2025 May 23;16:1543112. doi: 10.3389/fphar.2025.1543112. eCollection 2025.
5
Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma.胰腺导管腺癌的表型异质性与肿瘤免疫微环境导向治疗策略
Front Immunol. 2025 Mar 31;16:1573522. doi: 10.3389/fimmu.2025.1573522. eCollection 2025.
6
Concurrent Invasive Ductal Carcinoma and Pancreatic Intraepithelial Neoplasia in Duodenal Heterotopic Pancreas: A Case Report.十二指肠异位胰腺并发浸润性导管癌和胰腺上皮内瘤变:一例报告
Oman Med J. 2024 Nov 30;39(6):e699. doi: 10.5001/omj.2024.35. eCollection 2024 Nov.
7
Pancreatic cancer: Future challenges and new perspectives for an early diagnosis.胰腺癌:早期诊断面临的未来挑战与新视角
World J Clin Oncol. 2025 Feb 24;16(2):97248. doi: 10.5306/wjco.v16.i2.97248.
8
Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development.USP9X/NDRG3对KRAS的抗蛋白水解调节在KRAS驱动的癌症发展中的作用
Nat Commun. 2025 Jan 16;16(1):628. doi: 10.1038/s41467-024-54476-8.
9
Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal Adenocarcinomas.胰腺导管腺癌起源于导管内乳头状黏液性肿瘤(IPMN)与起源于胰腺上皮内瘤变(PanIN)的分子通路及免疫特征分析
Int J Mol Sci. 2024 Dec 7;25(23):13164. doi: 10.3390/ijms252313164.
10
Understanding the risk of recurrence after resection of intraductal papillary mucinous neoplasm-associated adenocarcinoma: insights from a large multicenter study.了解导管内乳头状黏液性肿瘤相关腺癌切除术后的复发风险:来自一项大型多中心研究的见解。
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):1041-1044. doi: 10.21037/hbsn-24-583. Epub 2024 Nov 8.
胰腺导管内乳头状黏液性肿瘤囊液中高级别上皮异型性的细胞学标准。
Cancer Cytopathol. 2014 Jan;122(1):40-7. doi: 10.1002/cncy.21344. Epub 2013 Aug 12.
4
Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.MUC4 黏蛋白的表达主要见于胰腺导管内乳头状黏液性肿瘤的肠型。
Pancreas. 2013 Oct;42(7):1120-8. doi: 10.1097/MPA.0b013e3182965915.
5
The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.胰腺导管内管状乳头肿瘤和胃型、幽门腺型的胰腺导管内乳头状黏液性肿瘤的离散性质和独特分子特征。
J Pathol. 2013 Nov;231(3):335-41. doi: 10.1002/path.4242.
6
Clinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.胰腺导管内乳头状黏液性肿瘤(IPMN)中激活的 GNAS 突变的临床病理相关性。
Ann Surg Oncol. 2013 Nov;20(12):3802-8. doi: 10.1245/s10434-013-3096-1. Epub 2013 Jul 12.
7
Precancerous lesions of the pancreas.胰腺的癌前病变。
Best Pract Res Clin Gastroenterol. 2013 Apr;27(2):299-322. doi: 10.1016/j.bpg.2013.04.001.
8
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma.胰头切除术后导管腺癌患者的生存情况评估。
BMC Surg. 2013 Apr 22;13:12. doi: 10.1186/1471-2482-13-12.
9
Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.胰腺内导管乳头状黏液性肿瘤(IPMN)患者的组织病理学亚型可预测其生存情况。
Ann Surg. 2013 Aug;258(2):324-30. doi: 10.1097/SLA.0b013e318287ab73.
10
EUS-guided pancreatic fluid aspiration for DNA analysis of KRAS and GNAS mutations for the evaluation of pancreatic cystic neoplasia: a pilot study.超声内镜引导下胰腺液体抽吸用于KRAS和GNAS突变的DNA分析以评估胰腺囊性肿瘤:一项初步研究
Gastrointest Endosc. 2013 Apr;77(4):669-70. doi: 10.1016/j.gie.2012.11.009.